Tuffy KM, Ahani B, Domachowske JB, Furuno K, et al. Molecular and phenotypic characteristics of respiratory syncytial virus isolates recovered from medically vulnerable children: An exploratory analysis of a phase 2/3 randomized, double-blind, palivizumab-controlled trial of nirsevimab (MEDLEY). Vaccine 2024;42:126276.
PMID: 39241352